Semiconductor Wars: Beyond the China-US Divide
China's recent block on Nvidia's H200 AI chip imports has caused a production halt among suppliers, escalating the U.S.-China tech rivalry. This protectionist measure is poised to accelerate the growth of China's domestic semiconductor industry and benefit international competitors to Nvidia.
Your Basket's Financial Footprint
This basket's total market capitalisation is 7,267,000.150700001 and is heavily concentrated in a few very large-cap constituents, anchoring its risk profile.
- Large-cap dominance generally implies lower volatility and closer tracking to broad market movements, reducing idiosyncratic risk.
- Suitable as a core, long-term holding within diversified portfolios rather than a short-term speculative position.
- Expect steady, long-term capital appreciation tendencies; do not expect rapid, explosive short-term gains.
NVDA: $4.53T
TSM: $1.43T
INTC: $224.00B
- Other
About This Group of Stocks
Our Expert Thinking
China's block on Nvidia's advanced AI chips marks a pivotal moment in the global tech rivalry. This protectionist move is reshaping the semiconductor landscape, forcing companies to adapt their strategies and supply chains. We've identified firms positioned to benefit from this geopolitical shift, whether through capturing diverted demand or strengthening domestic capabilities.
What You Need to Know
This group spans the entire semiconductor value chain, from chip designers and manufacturers to equipment suppliers and testing companies. These stocks operate in an increasingly fragmented market where geopolitical tensions directly impact business operations. The companies range from established industry giants to specialised players in critical supply chain segments.
Why These Stocks
Our analysts handpicked these companies based on their strategic positioning in the U.S.-China tech divide. Each stock represents a different angle on this theme - some may benefit from reduced competition, others from onshoring initiatives, and some from their critical role in global supply chains that can't easily be replicated.
Why You'll Want to Watch These Stocks
Historic Tech Rivalry Unfolds
You're witnessing a pivotal moment in global technology as the world's two largest economies reshape the semiconductor industry. This kind of structural shift often creates significant winners and losers.
Supply Chain Disruption = Opportunity
When established trade routes get blocked, smart money flows to companies that can fill the gap. Some of these firms are positioned to capture market share that was previously locked up.
Onshoring Boom in Motion
Governments are pouring billions into domestic chip manufacturing. Companies with the right capabilities and locations could see massive demand increases as nations prioritise supply chain security.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Alphabet AI Stocks | $4 Trillion Market Cap Impact
Alphabet's achievement of a $4 trillion market cap, driven by its AI leadership and a new partnership with Apple, signals an escalation in the tech industry's AI arms race. This creates a compelling investment opportunity in the network of companies, from hardware suppliers to software developers, that support and benefit from its expanding AI ecosystem.
Domestic Stocks May Weather Transatlantic Risks
The U.S. has imposed tariffs on key European allies to pressure them into a deal for Greenland, sparking significant transatlantic trade friction. This theme focuses on companies insulated from European trade that may benefit from a shift toward domestic or non-European sourcing.
Boston Scientific Penumbra Deal (Cardiovascular M&A)
Boston Scientific is set to acquire Penumbra for $14.5 billion, marking a significant expansion into the high-growth thrombectomy and neurovascular device markets. This major consolidation could catalyze further M&A activity, creating investment opportunities among other innovative companies in the cardiovascular sector.